Reuters logo
BRIEF-Jazz Pharmaceuticals Q2 adjusted earnings per share $2.56
2017年8月8日 / 晚上8点52分 / 3 个月前

BRIEF-Jazz Pharmaceuticals Q2 adjusted earnings per share $2.56

Aug 8 (Reuters) - Jazz Pharmaceuticals Plc

* Jazz Pharmaceuticals announces second quarter 2017 financial results

* Q2 adjusted earnings per share $2.56

* Q2 GAAP earnings per share $1.72

* Q2 earnings per share view $2.75 -- Thomson Reuters I/B/E/S

* Jazz Pharmaceuticals Plc says affirming its full year 2017 financial guidance

* Qtrly total revenues $394.4 million , up 3 percent

* FY2017 earnings per share view $11.02, revenue view $1.66 billion -- Thomson Reuters I/B/E/S

* Q2 revenue view $410.8 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below